Inolife Sciences is an emerging specialty medical device company focused on developing and commercializing novel drug delivery technologies. Inolife commercializes patented and FDA-cleared needle-free injection devices. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection that improve patients’ quality of life by making medicines easier to administer, work better, and remove the anxiety and inconvenience associated with hypodermic needle injections.
The “Inojex System” provides for needle-free delivery of a drug or biologic as a liquid jet into the subcutaneous tissue.
The patented “Nanojex System” painlessly delivers medicines through the skin by using a gas jet to accelerate powdered drug formulas or protein nanoparticles to supersonic speed with a single-use, disposable, hand-held device.
Inolife Sciences is developing products based on this proprietary delivery technologies in several important fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anaemia, neutropenia, autoimmune rheumatoid arthritis, growth & fertility hormone and psoriasis, and for DNA and conventional/pediatric vaccines.
Our R&D focus is specifically on the market for injectable drugs, biosimilar biologic molecules, and vaccines. Our Needle-Free technology is ideal for a broad spectrum of uses, such as Diabetes, Dental Anaesthesia, Vaccination, Autoimmune Disease, Erectile Dysfunction, Cancer, Growth Hormone, Cosmetics, and Veterinary.
Inojex injector delivers a fine stream of medication subcutaneously (under the skin) without using a needle. The injections with the InoLife Inojex are virtually pain-free and do not lead to tissue damage on long term use. The InoLife injector is a reusable device, which utilizes disposable ampoules and other accessories.